LANGUAGE:
LANGUAGE:
Our people are our pride, helping companies resonate with their customers for 20+ years.
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Solutions
Our experts know the in-and-outs of your industry & its challenges.
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Our people are our pride, helping companies resonate with their customers for 20+ years.
About Us
Key Facts
Leadership
Insights
News
Trust Center
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Content Services
Technical Writing
Training & eLearning
Financial Reports
Multicultural Marketing
Digital Experience Assessments
Translation Services
Translation
Video Localization
Software Localization
Website Localization
Translation for Regulated Companies
Interpretation
Multilingual SEO & Digital Marketing
Content Optimization
Testing Services
Functional QA & Testing
Compatibility Testing
Interoperability Testing
Performance Testing
Accessibility Testing
UX/CX Testing
Solutions
Digital Marketing
Live Events
Machine Translation
Our Knowledge Hubs
Positive Patient Outcomes
Future of Localization
Innovation to Immunity
COVID-19 Resource Center
Disruption Series
Patient Engagement
Lionbridge Insights
Our experts know the in-and-outs of your industry & its challenges.
Life Sciences
Banking & Finance
Retail
E-Commerce
Games
Automotive
Consumer Packaged Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Lainguage Cloud™ Platform
Connectivity
Translation Community
Workflow Technology
Smairt Content™
Smairt MT™
Smairt Data™
Language Quality
Analytics
SELECT LANGUAGE:
Plain language summaries, which provide a patient- and public-friendly summary of clinical trial results, are not new to clinical investigations. But a recent push for transparency and ethical disclosure of research results in the medical community has catapulted these documents into the spotlight.
In the EU, an upcoming Clinical Trial regulation makes mandatory the provision of plain language summaries by all sponsors in the European Union conducting:
Find out more about our Life Sciences Services.
Under the new regulation, the European Commission will establish a publicly-accessible EU database to ensure a sufficient level of transparency within clinical research and grant the public access to relevant information on clinical trials, including plain language summaries of clinical trial results. This legal enforcement now requires clinical trial sponsors to develop standard internal processes and to dedicate resources to clinical trial disclosure activities.
General consensus suggests that disclosing research results to public audiences in plain language is necessary for three important reasons:
Additionally, patients can be valuable sources of information to researchers striving to understand the effects of a disease on a patient's life, design protocol procedures, or ensure the readability and usability of labeling and product information. Communicating to a global population through a plain language summary broadens a researcher's ability to gain important insights and allows more patients to benefit from the research.
While the EU has taken an early lead in regulating the disclosure of clinical research results in plain language, other countries and regions are expected to follow suit.
As a scientist newly tasked with creating these plain language summaries, how can you ensure you communicate your science story to the general public effectively, cost-efficiently, and in their native language?
It's an important and complex task, and Lionbridge can help.
Interested in learning how to author and translate plain language summaries successfully? Download our whitepaper for our tips.